Evaluation of Renal Function and Stent Durability Following Resonance Stent Placement for Benign Disease
Journal of Endourology · 2023
DOI: 10.1089/end.2022.0822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endourology, 2023. Verfasst von Rohit Bhatt und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of California, Irvine, Orange, California, USA. Hauptthemen laut MEDLINE: Ureteral Obstruction, Ureter. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
The metal-based Resonance stent (RS) has traditionally been placed in patients with malignant ureteral obstruction; as such, the long-term utility of RS among patients with benign ureteral obstruction (BUO) remains underinvestigated.
Methods
We retrospectively reviewed our database for patients with BUO who underwent RS placement between 2010 and 2020. The impact of chronic RS placement on renal function was evaluated by estimated serum creatinine-based glomerular filtration rate (eGFR), furosemide renal scan, and CT-based renal parenchymal volume measurement. The number of and reason for RS stent exchanges during the follow-up period, incidence of encrustation, and the average indwell time were recorded. A cost analysis of placing the RS vs a polymeric stent was performed.
Results
Among 43 RS patients with BUO, at a mean follow-up of 26 months, there was no change in eGFR (p = 0.99), parenchymal volume (p = 0.44), or split renal function of the stent-bearing side on renal scan (p = 0.48). The mean RS indwell time was 9.7 months. Eleven patients (26%) underwent premature stent replacement (6 cases) or removal (5 cases). Stents in 9 patients (32%) were encrusted, of which 4 (44%) required laser lithotripsy. Overall, 25 patients (58%) and 12 patients (28%) had a mean stent indwell time of ≥6 months and ≥12 months, respectively. Placing an RS resulted in a 52%, 37%, and 5.6% cost reduction compared with a regular polymeric stent placement, where it was exchanged every 6, 4, or 3 months, respectively.
Conclusions
RS deployment in the patient with a BUO results in cost-effective maintenance of renal function and of renal parenchymal volume at a mean follow-up of 2 years; however, only 28% of patients fulfilled the 1-year criterion for RS indwell time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of California, Irvine, Orange, California, USA.
ORCID-Profile: Kalon L Morgan
Zitieren
APA
Bhatt, R., Vo, K., Cumpanas, A. D., Morgan, K. L., Shin, A., Ali, S. N., Rojhani, A., Peta, A., Brevik, A., Tano, Z. E., Jiang, P., Patel, R. M., Clayman, R. V., & Landman, J. (2023). Evaluation of Renal Function and Stent Durability Following Resonance Stent Placement for Benign Disease. Journal of Endourology. https://doi.org/10.1089/end.2022.0822
Vancouver
Bhatt R, Vo K, Cumpanas AD, Morgan KL, Shin A, Ali SN, et al. Evaluation of Renal Function and Stent Durability Following Resonance Stent Placement for Benign Disease. Journal of Endourology. 2023. doi:10.1089/end.2022.0822
BibTeX
@article{Bhatt2023,
author = {Bhatt, Rohit and Vo, Kelvin and Cumpanas, Andrei D and Morgan, Kalon L and Shin, Andrew and Ali, Sohrab N and Rojhani, Allen and Peta, Akhil and Brevik, Andrew and Tano, Zachary E and Jiang, Pengbo and Patel, Roshan M and Clayman, Ralph V and Landman, Jaime},
title = {Evaluation of Renal Function and Stent Durability Following Resonance Stent Placement for Benign Disease},
journal = {Journal of Endourology},
year = {2023},
doi = {10.1089/end.2022.0822}
}
EUVIMED